Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Ovary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01167842
What this trial is testing

Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)

Who this might be right for
Breast CancerOvarian Cancer
University of Washington 31
Testing effectiveness (Phase 2)Looking for participantsNCT05071937
What this trial is testing

ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Alexander B Olawaiye, MD 33
Early research (Phase 1)Study completedNCT02344095
What this trial is testing

A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer

Who this might be right for
Epithelial Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Seoul National University Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT00082212
What this trial is testing

A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma

Who this might be right for
Ovarian Cancer
Eli Lilly and Company 25
Testing effectiveness (Phase 2)Looking for participantsNCT07261683
What this trial is testing

Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerImmunotherapyPembrolizumab
Obstetrics & Gynecology Hospital of Fudan University 20
Large-scale testing (Phase 3)Study completedNCT03534453
What this trial is testing

Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Who this might be right for
Relapsed Ovarian CancerFollowing Complete or Partial Response to Platinum Based ChemotherapyPlatinum Sensitive
AstraZeneca 229
Early research (Phase 1)Study completedNCT00692900
What this trial is testing

Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
University of Pittsburgh 25
Early research (Phase 1)Study completedNCT02014337
What this trial is testing

Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

Who this might be right for
Breast CancerOvarian Epithelial Cancer RecurrentSarcoma+4 more
Corcept Therapeutics 37
Testing effectiveness (Phase 2)UnknownNCT03539328
What this trial is testing

Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 138
Not applicableUnknownNCT06010667
What this trial is testing

A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian Cancer
Hebei Medical University Fourth Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT05112601
What this trial is testing

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+6 more
National Cancer Institute (NCI) 81
Testing effectiveness (Phase 2)WithdrawnNCT02756130
What this trial is testing

Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)

Who this might be right for
High Grade Fallopian Tube Serous AdenocarcinomaHigh Grade Ovarian Serous AdenocarcinomaPrimary Peritoneal High Grade Serous Adenocarcinoma+3 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00620295
What this trial is testing

Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
Masonic Cancer Center, University of Minnesota 17
Testing effectiveness (Phase 2)Study completedNCT00058552
What this trial is testing

Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Genentech, Inc. 129
Early research (Phase 1)UnknownNCT00982631
What this trial is testing

Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer

Who this might be right for
Advanced/Recurrent Breast CancerEndometrial CancerOvarian Cancer
Radboud University Medical Center 30
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Testing effectiveness (Phase 2)Ended earlyNCT05363605
What this trial is testing

[225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more
Fusion Pharmaceuticals Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT01133756
What this trial is testing

E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125

Who this might be right for
Ovarian Cancer
Eisai Inc. 7
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT00683241
What this trial is testing

A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cancer
Abramson Cancer Center at Penn Medicine 36
Next Page